Literature DB >> 31204678

Dyspnoea in the GLOBAL LEADERS trial - Authors' reply.

Peter Jüni1, Pascal Vranckx2, Marco Valgimgli3, Patrick Serruys4, Stephan Windecker5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31204678     DOI： 10.1016/S0140-6736(19)30685-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial.

Authors:  Pascal Vranckx; Marco Valgimigli; Ayodele Odutayo; Patrick W Serruys; Christian Hamm; Philippe Gabriel Steg; Dik Heg; Eugene P Mc Fadden; Yoshinobu Onuma; Edouard Benit; Luc Janssens; Roberto Diletti; Maurizio Ferrario; Kurt Huber; Lorenz Räber; Stephan Windecker; Peter Jüni
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.